Experimental Gene Therapy Slows Huntington's Disease By 75%

Techno-skeptic narrative

While promising, this expensive treatment requiring complex 18-hour brain surgery will remain inaccessible to most patients who desperately need it. The results are based on only 29 patients without peer review, and the therapy doesn't cure the disease but merely delays the inevitable, gradual decline. Gene therapies often carry hefty price tags that healthcare systems struggle to afford, further exacerbating inequalities in access to care.